Mucosa-associated lymphoid tissue-type lymphomas occurring in post- transplantation patients

American Journal of Surgical Pathology

Volumn 24, Issue 1, 2000, Pages 100-106

  Hsi, Eric D ^c   Singleton, T P ^a   Swinnen, L ^b   Dunphy, C H ^d   Alkan, S ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NONE

Author keywords

Lymphoma; Mucosa associated lymphoid tissue; Transplantation

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL FEATURE; EPSTEIN BARR VIRUS; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; POSTOPERATIVE PERIOD; TRANSPLANTATION;

COMBINED MODALITY THERAPY; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; PAROTID GLAND; PAROTID NEOPLASMS; RECURRENCE; RNA, VIRAL; STOMACH; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION;

EID: 0033985841     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200001000-00012     Document Type: Article

References (49)

1. Alkan S, Karcher DS, Newman MA, Cohen P. Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori. Lancet 1996;348:268-9.
2. Aozasa K. Hashimoto's thyroiditis as a risk factor of thyroid lymphoma. Acta Pathol Jpn 1990;40:459-68.
3. Ascoli V, Lo Coco F, Artini M, Levrero M, Martelli M, Negro F. Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol 1998;109:600-9.
4. Aviles A, Duque G, Talavera A, Guzman R. Interferon alpha 2b as maintenance therapy in low-grade malignant lymphoma improves duration of remission and survival. Leuk Lymphoma 1996;20: 495-9.
5. Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995;345:1591-4.
6. Cammarota G, Papa A, Tursi A, Cuoco L, Fedeli G, Gasbarrini G. Pathogenesis of MALT lymphoma: an antigen-dependent process [Letter]. Gastroenterology 1997;113:1810.
7. Cesarman E, Chadburn A, Liu YF, Migliazza A, Dalla-Favera R, Knowles DM. BCL-6 gene mutations in post-transplantation lymphoproliferative disorders predict response to therapy and guide clinical outcome. Blood 1998;92:2294-302.
8. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center. Transplantation 1993;56:88-96.
9. Frizzera G. Atypical lymphoproliferative disorders. In: Knowles DM, ed. Neoplastic hematopathology. Baltimore: Williams and Wilkins, 1992:472-81.
10. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981;41:4262-79.
11. Greiner A, Knorr C, Qin Y, et al. Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol 1997;150:1583-93.
12. Greiner A, Marx A, Heesemann J, Leebmann J, Schmausser B, Muller-Hermelink HK. Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest 1994;70:572-8.
13. Hanson MN, Morrison VA, Peterson BA, et al. Post-transplant T-cell lymphoproliferative disorders - an aggressive, late complication of solid-organ transplantation. Blood 1996;88:3626-33.
14. Hanto DW, Frizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 1981;41: 4253-61.
15. Hauer AC, Finn TM, MacDonald TT, Spencer J, Isaacson PG. Analysis of TH1 and TH2 cytokine production in low-grade B cell gastric MALT-type lymphomas stimulated in vitro with Helicobacter pylori. J Clin Pathol 1997;50:957-9.
16. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985;312:601-4.
17. Hsi ED, Eisbruch A, Greenson JK, Singleton TP, Ross CW, Schnitzer B. Classification of primary gastric lymphomas according to histologic features. Am J Surg Pathol 1998;22:17-27.
18. Hsi ED, Greenson JK, Singleton TP, Siddiqui J, Schnitzer B, Ross CW. Detection of immunoglobulin heavy chain gene rearrangement by polymerase chain reaction in chronic active gastritis associated with Helicobacter pylori. Hum Pathol 1996;27:290-6.
19. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342:571-4.
20. Hussell T, Isaacson PG, Crabtree JE, Spencer J. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 1996; 178:122-7.
21. Hussell T, Isaacson PG, Spencer J. A role for antigen in the evolution of gastrointestinal MALT-type B cell lymphoma. Adv Exp Med Biol 1995;371A:145-7.
22. Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol 1988;19: 1315-26.
23. Hyjek E, Smith WJ, Isaacson PG. Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum Pathol 1988;19:766-76.
24. Joshi VV, Gagnon GA, Chadwick EG, et al. The spectrum of mucosa-associated lymphoid tissue lesions in pediatric patients infected with HIV: a clinicopathologic study of six cases. Am J Clin Pathol 1997;107:592-600.
25. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
26. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three dis-tinct categories of post-transplantation lymphoproliferative disorders. Blood 1995;85:552-65.
27. Locker J, Nalesnik M. Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 1989;135: 977-87.
28. Montalban C, Castrillo JM, Lopez-Abente G, et al. Other cancers in patients with gastric MALT lymphoma. Leuk Lymphoma 1999; 33:161-8.
29. Montalban C, Manzanal A, Boixeda D, et al. Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies. Ann Oncol 1997;8(Suppl. 2):37-9.
30. Nakamura S, Aoyagi K, Furuse M, et al. B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. Am J Pathol 1998;152: 1271-9.
31. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988;133:173-92.
32. Nalesnik MA, Locker J, Jaffe R, et al. Clonal characteristics of post-transplant lymphoproliferative disorders. Transplant Proc 1988;20:280-3.
33. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
34. Peng H, Du M, Diss TC, Isaacson PG, Pan L. Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma. Histopathology 1997;30:425-9.
35. Savio A, Franzin G, Wotherspoon AC, et al. Diagnosis and post-treatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood 1996;87:1255-60.
36. Savoie A, Perpete C, Carpentier L, Joncas J, Alfieri C. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliterative disease. Blood 1994;83:2715-22.
37. Silvestri F, Pipan C, Barillari G, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996;87:4296-301.
38. Smith JL, Wilkinson AH, Hunsicker LG, et al. Increased frequency of post-transplant lymphomas in patients treated with cyclosporin, azathioprine, and prednisone. Transplant Proc 1989;21:3199-200.
39. Swerdlow SH. Post-transplant lymphoproliferative disorders, transplantation, Epstein-Barr virus, and lymphoma. Classification of the post-transplant lymphoproliferative disorders - from the past to the present. Semin Diagn Pathol 1997;14:2-7.
40. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990;323:1723-8.
41. Swinnen LJ, Mullen GM, Carr TJ, Costanzo MR, Fisher RI. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 1995;86:3333-40.
42. Tbakhi A, Totos G, Hauser-Kronberger C, et al. Fixation conditions for DNA and RNA in situ hybridization: a reassessment of molecular morphology dogma. Am J Pathol 1998;152:35-41.
43. Teruya-Feldstein J, Temeck BK, Sloas MM, et al. Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient. Am J Surg Pathol 1995:19:357-63.
44. Walker RC, Marshall WF, Strickler JG, et al. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis 1995;20:1346-53.
45. Wotherspoon AC, Diss TC, Pan L, Singh N, Whelan J, Isaacson PG. Low grade gastric B-cell lymphoma of mucosa associated lymphoid tissue in immunocompromised patients. Histopathology 1996;28:129-34.
46. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7.
47. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
48. Zein NN, Rakela J. Interferon therapy in hepatitis C. Semin Gastrointest Dis 1995;6:46-53.
49. Zucca E, Bertoni F, Roggero E, et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998;338:804-10.